Javascript must be enabled for this website to work.

#script { display:none; } #noScript{ width: 350px; height: 175px; text-align: center; background: white; padding: 35px; display: block; margin-top: -87px; top: 50%; position: absolute; border-bottom: 1px solid #c2c2c2; border-left: 1px solid #e6e6e6; border-right: 1px solid #e6e6e6; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; margin-left: 50%; left: -175px; } #noScript img{width:100%;} body{background:#f7f7f7;}

respiratory

COPD

Sertraline no help in chronic breathlessness

By Mardi Chapman

6 Nov 2018

Sertraline has no role in the management of chronic breathlessness in patients with advanced disease such as COPD, primary lung cancer and other restrictive lung disease. An Australian study randomised 249 patients to either daily oral sertraline (25-100mg) or placebo in addition to their usual care and up to eight doses of immediate release oral ...

Already a member?

Enter your email to keep reading.

Not a member yet?

Join now for free, independent news relevant to your specialty. the limbic is intended for practicing health care professionals only.

Title: *

Name: *

Email: *

AHPRA Number: *

Can't remember your AHPRA number? Search for it here

What's your primary area of interest? *

The limbic's weekly newsletter is a round up of key news highlights that's relevant to your specialty. The newsletter may contain advertising and educational or promotional material from carefully selected industry partners including pharmaceutical companies, government and not-for-profit organisations.

You will not receive advertisers only emails and your details will not be shared with any other party.

I would like to receive the limbic newsletter *

I have read and agree to the limbic Terms and Conditions & Privacy Policy *